MapLight Therapeutics (MPLT) Other Non Operating Income (2024 - 2025)
MapLight Therapeutics recorded quarterly Other Non Operating Income of $1.4 million in Q4 2025, up 155.93% quarter-over-quarter from $531000.0 in Q3 2025, and up 109.4% year-over-year from $649000.0 in Q4 2024.
MapLight Therapeutics' Other Non Operating Income history runs 2 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- In Q4 2025, Other Non Operating Income rose 109.4% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $3.3 million (changed N/A YoY), while the FY2025 annual figure was $2.4 million, up 30.57% from the prior year.
- Other Non Operating Income came in at $1.4 million for Q4 2025 at MapLight Therapeutics, up from $531000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.4 million in Q4 2025 to a low of $531000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | MapLight Therapeutics | 254.43 Mn | 254.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 531,000.00 |
| Dec 31, 2024 | 649,000.00 |
| Sep 30, 2024 | 797,000.00 |